Table 1 “KEGG 2019 Human” category of Enrichr for 52 genes selected by applying PCA-based unsupervised FE to gene expression profiles. Eleven terms with adjusted P-values less than 0.05 are listed.

Ribosome

19/153

\(1.20 \times 10^{-27}\)

\(3.68 \times 10^{-25}\)

Thermogenesis

13/231

\(1.98 \times 10^{-14}\)

\(3.05 \times 10^{-12}\)

Oxidative phosphorylation

11/133

\(3.54 \times 10^{-14}\)

\(3.63 \times 10^{-12}\)

Parkinson disease

11/142

\(7.35 \times 10^{-14}\)

\(5.66 \times 10^{-12}\)

Glycolysis/gluconeogenesis

8/68

\(7.80 \times 10^{-12}\)

\(4.80 \times 10^{-10}\)

HIF-1 signaling pathway

6/100

\(2.27 \times 10^{-7}\)

\(1.16 \times 10^{-5}\)

Alzheimer disease

7/171

\(2.86 \times 10^{-7}\)

\(1.26 \times 10^{-5}\)

Huntington disease

6/193

\(1.05 \times 10^{-5}\)

\(4.05 \times 10^{-4}\)

Retrograde endocannabinoid signaling

5/148

\(4.07 \times 10^{-5}\)

\(1.39 \times 10^{-3}\)

Cardiac muscle contraction

4/78

\(5.03 \times 10^{-5}\)

\(1.55 \times 10^{-3}\)

Non-alcoholic fatty liver disease (NAFLD)

4/149

\(6.07 \times 10^{-4}\)

\(1.70 \times 10^{-2}\)